QVQ Holding b.v. as
partner of a larger consortium and in
collaboration with its daughter company Orthros TR b.v. -has received a
substantial grant from EU and Op Oost [NL] to develop VHH to detect and repair
Osteoarthritis, an age related disease affecting over 100.000.000 people around
the globe [see our products in this area].
Noticeable: the VHH developed by QVQ may have therapeutic
effects on dogs and horses suffering from OA as well.